Table 4.
Microbiological parameters in Treatment Group III patients (N = 2).
| Post-Systemic Metronidazole Plus Ciprofloxacin, and Metronidazole Plus Amoxicillin/Clavulanic Acid | |||
|---|---|---|---|
| Microbial Species | Baseline | 1 Month Post-Treatment | 1 Year Post-Treatment |
| Periodontal Pathogens: | |||
| Aggregatibacter actinomycetemcomitans | 2 (7.2) § | 0 § | 0 § |
| Porphyromonas gingivalis | 0 | 0 | 0 |
| Prevotella intermedia/nigrescens | 2 (6.8) | 0 | 0 |
| Parvimonas micra | 2 (7.4) | 1 (1.6) | 0 |
| Campylobacter rectus | 2 (18.7) | 1 (0.1) | 1 (1.3) |
| Superinfecting Species: | |||
| enteric rods/pseudomonads | 2 (19.7) § | 0 § | 0 § |
| staphylococci | 0 | 0 | 0 |
| Enterococcus faecalis | 0 | 0 | 0 |
| Candida species | 0 | 0 | 1 (0.01) |
| Mean % total recovery of test periodontal pathogens and superinfecting species (SD) † | 50.7 (19.9) | 0.9 (1.1) | 0.7 (0.9) |
| No. (%) of patients with high-risk subgingival microbiota ‡ | 2 (100) | 0 (0) | 0 (0) |
| Mean % recovery of viridans streptococci (SD) | 6.5 (5.7) | 16.6 (8.4) | 31.0 (19.0) |
See Table 2 footnote for symbol definitions.